We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.48%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$421M
AUM Growth
-$129M
(-23%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-32.66%
Top 10 Holdings %
Top 10 Hldgs %
15.04%
Holding
968
New
354
Increased
90
Reduced
100
Closed
424
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$14.8M |
| 2 |
Bank of America
BAC
|
+$5.51M |
| 3 |
Wells Fargo
WFC
|
+$3.74M |
| 4 |
British American Tobacco
BTI
|
+$3.71M |
| 5 |
AerCap
AER
|
+$3.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$4.93M |
| 2 |
Agilent Technologies
A
|
+$4.8M |
| 3 |
Nike
NKE
|
+$4.65M |
| 4 |
NextEra Energy
NEE
|
+$4.37M |
| 5 |
Thomson Reuters
TRI
|
+$4.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.3% |
| 2 | Financials | 14.62% |
| 3 | Healthcare | 11.42% |
| 4 | Consumer Discretionary | 10.35% |
| 5 | Industrials | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Takeda Pharmaceutical
TAK
$56B
| $271K | 0.06% |
+19,919
| New | +$279K |
|
|
VPU
427
Vanguard Utilities ETF
VPU
$8.74B
| $270K | 0.06% |
+1,727
| New | +$255K |
|
428
BorgWarner
BWA
$12.9B
| $268K | 0.06% |
+6,751
| New | +$271K |
|
429
Portland General Electric
POR
$5.93B
| $266K | 0.06% |
+5,032
| New | +$251K |
|
430
Owens Corning
OC
$11.6B
| $265K | 0.06% |
+2,932
| New | +$266K |
|
431
Becton Dickinson
BDX
$45.3B
| $264K | 0.06% |
1,077
-3,985
| -79% | -$955K |
|
432
Brown-Forman Class B
BF.B
$13.2B
| $264K | 0.06% |
3,622
-12,629
| -78% | -$898K |
|
433
iShares Global REIT ETF
REET
$5.2B
| $264K | 0.06% |
+8,632
| New | +$252K |
|
434
Shoals Technologies Group
SHLS
$1.48B
| $263K | 0.06% |
+10,832
| New | +$311K |
|
|
GRMN
435
Garmin
GRMN
$48.9B
| $262K | 0.06% |
1,924
-14,412
| -88% | -$2.08M |
|
436
NetEase
NTES
$82.2B
| $262K | 0.06% |
+2,578
| New | +$262K |
|
|
FLOW
437
DELISTED
SPX FLOW, Inc.
FLOW
| $261K | 0.06% |
+3,022
| New | +$243K |
|
438
Papa John's
PZZA
$1.03B
| $260K | 0.06% |
+1,949
| New | +$249K |
|
439
BioNTech
BNTX
$23.3B
| $259K | 0.06% |
1,003
-5,258
| -84% | -$1.44M |
|
440
iShares US Medical Devices ETF
IHI
$3.14B
| $259K | 0.06% |
3,932
-7,862
| -67% | -$503K |
|
|
P
441
Everpure Inc
P
$24B
| $258K | 0.06% |
7,930
-15,299
| -66% | -$444K |
|
442
KT
KT
$8.97B
| $256K | 0.06% |
+20,380
| New | +$267K |
|
443
Netflix
NFLX
$305B
| $254K | 0.06% |
+4,210
| New | +$269K |
|
444
Sabra Healthcare REIT
SBRA
$5.66B
| $254K | 0.06% |
18,739
-15,308
| -45% | -$217K |
|
|
NATI
445
DELISTED
National Instruments Corp
NATI
| $254K | 0.06% |
+5,811
| New | +$247K |
|
446
Rapid7
RPD
$664M
| $253K | 0.06% |
2,152
-820
| -28% | -$101K |
|
447
Eastern Bankshares
EBC
$5.35B
| $252K | 0.06% |
+12,473
| New | +$259K |
|
448
Ultragenyx Pharmaceutical
RARE
$2.54B
| $252K | 0.06% |
+2,998
| New | +$244K |
|
|
BBBY
449
DELISTED
Bed Bath & Beyond Inc
BBBY
| $252K | 0.06% |
+17,284
| New | +$302K |
|
450
Brunswick
BC
$5.39B
| $250K | 0.06% |
+2,479
| New | +$243K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q4 2021 Portfolio in Review
As of Q4 2021, Y-Intercept (HK) held 968 positions worth $421M, down 23% from $550M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Y-Intercept (HK) withdrew a net $138M in Q4 2021, closing 424 positions and reducing 100 holdings. Its most notable exit was Royal Dutch Shell PLC ADS Class A, an estimated $4.93M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Y-Intercept (HK) opened a new position in British American Tobacco worth $3.9M.
- Y-Intercept (HK)'s largest Q4 2021 buy was British American Tobacco: 104,352 shares worth $3.9M.
- Y-Intercept (HK) added most to Apple in Q4 2021, an estimated $14.8M increase.
- Y-Intercept (HK)'s biggest Q4 2021 reduction was Thomson Reuters, cutting an estimated $4.34M.
- Y-Intercept (HK) fully exited Royal Dutch Shell PLC ADS Class A in Q4 2021, selling an estimated $4.93M.
- Y-Intercept (HK)'s ten largest holdings make up 15% of its $421M portfolio in Q4 2021.
- Y-Intercept (HK) opened 354 new positions and closed 424 in Q4 2021.
- Y-Intercept (HK)'s portfolio value fell 23% quarter-over-quarter to $421M.
Based on Y-Intercept (HK)'s 13F filing for Q4 2021, filed 14 Feb 2022.